학술논문

EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 94건 | 목록 1~20
Electronic Resource
Maul, J-T; Navarini, A A; Sommer, R; Anzengruber, F; Sorbe, C; Mrowietz, U; Drach, M; Blome, C; Boehncke, W-H; Thaci, D; Reich, K; von Kiedrowski, R; Körber, A; Yawalkar, N; Mainetti, C; Laffitte, E; Streit, M; Rustenbach, S; Conrad, C; Borradori, L; Gilliet, M; Cozzio, A; Itin, P; Häusermann, P; French, L E; Radtke, M A; Augustin, M (2019). Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice. Journal of the European Academy of Dermatology and Venerology, 33(4):700-708.
Editorial & Opinion
Joos L; Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.; Vetterli F; Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.; Jaeger T; PATHOdiagnostics, St Gallen, Switzerland.; Cozzio A; Department of Dermatology, Kantonsspital St Gallen, St Gallen, Switzerland.; von Kempis J; Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.; Rubbert-Roth A; Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.
Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2230 (Electronic) Linking ISSN: 03076938 NLM ISO Abbreviation: Clin Exp Dermatol Subsets: MEDLINE
Electronic Resource
Adamo, S; Nilsson, J; Krebs, A; Steiner, U; Cozzio, A; French, L E; Kolios, A G A (2018). Successful treatment of SAPHO syndrome with apremilast. British Journal of Dermatology, 179(4):959-962.
Electronic Resource
Roider, E; Signer, C; Fehrenbacher, B; Metzler, G; Schaller, M; Kamarachev, J; Kerl, K; Balabanov, S; Jochum, W; Hoetzenecker, W; Cozzio, A; French, L; Dummer, R; Guenova, E (2018). Individualized treatment approaches for Langerhans cell histiocytosis. British Journal of Dermatology, 178(6):1423-1424.
Electronic Resource
Kolios, Antonios G A; Hafner, Jürg; Luder, C; Guenova, Emmanuella; Kerl, K; Kempf, Werner; Nilsson, J; French, L E; Cozzio, A (2018). Comparison of pyoderma gangrenosum and hypertensive ischemic leg ulcer Martorell in a Swiss cohort. British Journal of Dermatology, 178(2):e125-e126.
Academic Journal
Papadavid E; 1st and 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens Medical School, Athens, Greece.; Kapniari E; 1st and 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens Medical School, Athens, Greece.; Pappa V; 1st and 2nd Propaedeutic Department, Hematology Units, National and Kapodistrian University of Athens Medical School, Athens, Greece.; Nikolaou V; 1st and 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens Medical School, Athens, Greece.; Iliakis T; 1st and 2nd Propaedeutic Department, Hematology Units, National and Kapodistrian University of Athens Medical School, Athens, Greece.; Dalamaga M; 1st Department of Biological Chemistry, National and Kapodistrian University of Athens Medical School, Athens, Greece.; Jonak C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Porkert S; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Engelina S; Division of Dermatology, Tel Aviv University, Israel.; Quaglino P; Division of Dermatology, Tel Aviv University, Israel.; Ortiz-Romero PL; Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy.; Vico C; Department of Dermatology, 12 de Octubre Hospital, Medical School, University Compultense, Madrid, Spain.; Cozzio A; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.; Dimitriou F; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland.; Guiron R; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Tel Aviv University, Israel.; Guenova E; Department of Dermatology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.; Hodak E; Division of Dermatology, Tel Aviv University, Israel.; Bagot M; Dermatology Department, APHP, Saint-Louis Hospital, Université de Paris, Paris, France.; Inserm U976, Paris, France.; Scarisbrick J; Department of Dermatology, Centre for Rare Diseases, University Hospital Birmingham, Birmingham, UK.
Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Electronic Resource
Rinderknecht, J; Ali, H; Guenova, Emmanuella; Cozzio, A (2016). Negatives bullöses Pemphigoid. Dermatologica Helvetica, 28(10):22-23.
Academic Journal
Brüggen MC; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Medical Campus Davos, Davos, Switzerland.; Valencak J; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Stranzenbach R; Department of Dermatology, Venereology, Allergology and Phlebology, Johannes Wesling Medical Centre, University Hospital of Ruhr-University Bochum, Minden, Germany.; Li N; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Stadler R; Department of Dermatology, Venereology, Allergology and Phlebology, Johannes Wesling Medical Centre, University Hospital of Ruhr-University Bochum, Minden, Germany.; Jonak C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Bauer W; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Porkert S; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Blaschke A; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Meiss F; Department of Dermatology and Venereology, Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.; Nicolay JP; Department of Dermatology, Venereology and Allergology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.; Wehkamp U; Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany.; Schlaak M; Department of Dermatology and Venereology, University Hospital of Cologne, Cologne, Germany.; Department of Dermatology and Allergology, Ludwig-Maximilians-University of Munich, Munich, Germany.; Nguyen VA; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.; Romani N; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.; Cozzio A; Department of Dermatology, Venereology and Allergology, Canton Hospital of St. Gallen, St. Gallen, Switzerland.; Gayathri N; Department for Hematology, University Hospital of Zurich, Zurich, Switzerland.; Dimitriou F; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; French LE; Department of Dermatology and Allergology, Ludwig-Maximilians-University of Munich, Munich, Germany.; Dummer R; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Guenova E; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Department of Dermatology, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE
Academic Journal
Cazzaniga S; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Centro Studi GISED, Bergamo, Italy.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.; Anzengruber F; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.; Augustin M; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.; Boehncke WH; Division of Dermatology and Venereology, University Hospital of Geneva, Geneva, Switzerland.; Borradori L; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Conrad C; Department of Dermatology and Venereology, Hôpital de Beaumont, Lausanne University Hospital Center, Lausanne, Switzerland.; Cozzio A; Clinic of Dermatology and Allergology, Cantonal Hospital St Gallen, St Gallen, Switzerland.; Djamei V; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.; French LE; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.; Gilliet M; Department of Dermatology and Venereology, Hôpital de Beaumont, Lausanne University Hospital Center, Lausanne, Switzerland.; Häusermann P; Department of Dermatology, University Basel Hospital, Basel, Switzerland.; Heidemeyer K; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Itin P; Department of Dermatology, University Basel Hospital, Basel, Switzerland.; Kolios AGA; Department of Immunology, University Hospital Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Laffitte E; Division of Dermatology and Venereology, University Hospital of Geneva, Geneva, Switzerland.; Maul JT; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.; Mainetti C; Department of Dermatology, Regional Hospital Bellinzona, Bellinzona, Switzerland.; Naldi L; Centro Studi GISED, Bergamo, Italy.; Department of Dermatology, Azienda USL 8 Berica - San Bortolo Hospital, Vicenza, Italy.; Navarini AA; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.; Rustenbach SJ; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.; Simon D; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Sorbe C; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.; Streit M; Department of Dermatology and Allergology, Cantonal Hospital Aarau, Aarau, Switzerland.; Yawalkar N; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE
Academic Journal
Scarisbrick JJ; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Member of the UK Cutaneous Lymphoma Group.; Quaglino P; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Prince HM; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Papadavid E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Hodak E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Bagot M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Servitje O; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Berti E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Ortiz-Romero P; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Stadler R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Patsatsi A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Knobler R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Guenova E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Child F; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group.; Whittaker S; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Member of the UK Cutaneous Lymphoma Group.; Nikolaou V; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Tomasini C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Amitay I; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Prag Naveh H; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Ram-Wolff C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Battistella M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Alberti-Violetti S; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Stranzenbach R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Gargallo V; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Muniesa C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Koletsa T; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Jonak C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Porkert S; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Mitteldorf C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Estrach T; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Combalia A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Marschalko M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Csomor J; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Szepesi A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Cozzio A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Dummer R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Pimpinelli N; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Grandi V; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Beylot-Barry M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Pham-Ledard A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Wobser M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Geissinger E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Wehkamp U; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Weichenthal M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Cowan R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group.; Parry E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group.; Harris J; Member of the UK Cutaneous Lymphoma Group.; Wachsmuth R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group.; Turner D; Member of the UK Cutaneous Lymphoma Group.; Bates A; Member of the UK Cutaneous Lymphoma Group.; Healy E; Member of the UK Cutaneous Lymphoma Group.; Trautinger F; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Latzka J; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Yoo J; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Vydianath B; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Amel-Kashipaz R; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Marinos L; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Oikonomidi A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Stratigos A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Vignon-Pennamen MD; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Battistella M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Climent F; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Gonzalez-Barca E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Georgiou E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Senetta R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Zinzani P; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Vakeva L; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Ranki A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Busschots AM; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Hauben E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Bervoets A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Woei-A-Jin FJSH; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Matin R; Member of the UK Cutaneous Lymphoma Group.; Collins G; Member of the UK Cutaneous Lymphoma Group.; Weatherhead S; Member of the UK Cutaneous Lymphoma Group.; Frew J; Member of the UK Cutaneous Lymphoma Group.; Bayne M; Member of the UK Cutaneous Lymphoma Group.; Dunnill G; Member of the UK Cutaneous Lymphoma Group.; McKay P; Member of the UK Cutaneous Lymphoma Group.; Arumainathan A; Member of the UK Cutaneous Lymphoma Group.; Azurdia R; Member of the UK Cutaneous Lymphoma Group.; Benstead K; Member of the UK Cutaneous Lymphoma Group.; Twigger R; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Rieger K; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Brown R; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Sanches JA; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Miyashiro D; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Akilov O; Member of the Cutaneous Lymphoma International Consortium (CLIC).; McCann S; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Sahi H; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Damasco FM; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Querfeld C; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Folkes A; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Bur C; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Klemke CD; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Enz P; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Pujol R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Quint K; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Geskin L; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Hong E; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Evison F; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Vermeer M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Cerroni L; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Kempf W; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Kim Y; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Willemze R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.
Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Electronic Resource
Glatz, M; Achermann, Y; Kerl, K; Bosshard, P P; Cozzio, A (2013). Nodular secondary syphilis in a woman. BMJ Case Reports, 2013:1-5.
Electronic Resource
Morand, G; Vital, D; Pézier, T; Holzmann, D; Roessle, M; Cozzio, A; Huber, G F (2013). Merkel cell carcinoma of the head and neck: a single institutional experience. Journal of Skin Cancer, 2013:325086.
Electronic Resource
Kolios, A G A; Rusca, F; Reisenbauer, K; Cozzio, A; French, L E; Navarini, A A (2012). Topical treatment habits in psoriasis patients receiving adalimumab. Dermatology, 224(3):228-230.
Electronic Resource
Kaiser, C A; Cozzio, A; Hofbauer, Günther F L; Kamarashev, J; French, L E; Navarini, A A (2011). Disfiguring annular sarcoidosis improved by adalimumab. Case Reports in Dermatology, 3(2):103-106.
Electronic Resource
Läuchli, S; Hafner, J; Hofbauer, G F L; Cozzio, A; Urosevic-Maiwald, M (2011). Non-melanoma skin cancer. In: Dummer, R; Pittelkow, M; Iwatsuki, K; Green, A; Elwan, N M. Skin cancer - a world-wide perspective. Heidelberg, DE: Springer, 289-305.
검색 결과 제한하기
제한된 항목
[AR] Cozzio, A
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어